Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Joseph A. Boscarino, PhD, MPH
Dr. Boscarino is an Associate Researcher at the Henry Hood Center for Health Research, Geisinger Clinic, Danville, PA.
Authored Items
Lower Copay and Oral Administration: Predictors of First-Fill Adherence to New Asthma Prescriptions
Zackary Berger, MD, PhD
,
Ronald A. Lyon, MS
,
William Kimbrough, MD
,
Colleen Gillespie, PhD
,
Joseph A. Boscarino, PhD, MPH
,
G. Craig Wood, MS
,
Zhengmin Qian, MD, PhD
,
J. B. Jones, PhD, MBA
,
Nirav R. Shah, MD,MPH
June/July 2009, Vol 2, No 4
in
Practice Management
Last modified: September 6, 2013